This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview

This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

Refractory Outpatient HFrEF

Refractory Outpatient HFrEF

Format

Patient Case Study

Time to Complete

30 minutes

Released

May 13, 2019

Expires

May 13, 2020
Add to Queue


Maximum Credits

0.50 / AMA PRA Category 1 CreditTM

Accredited Provider



Sponsored by Academy for Continued Healthcare Learning

Commercial Supporter

Supported by an educational grant from Novartis Pharmaceuticals Corporation

Program Description

This case-based activity with a patient video illustrates a typical heart failure (HF) case of HF with reduced ejection fraction (HFrEF). Our faculty will discuss guideline recommendations, available clinical trial data, and dosing of optimal, targeted medical therapies for HFrEF.

Intended Audience

This activity is intended for interventional cardiologists, cardiologists, primary care physicians, nurses and others with an interest in the care of heart failure.

Educational Objectives

Upon proper completion of this activity, participants should be better able to:

  • Discuss strategies to optimize medical therapy in patients with heart failure
  • Interpret data from recent clinical trials and post-marketing studies with sacubitril/valsartan and ivabradine
  • Identify diverse HF patients who may benefit from the use of newer medical therapies
  • Employ multidisciplinary approaches to improve collaboration, transitions of care, and patient outcomes

Conflict of Interest Disclosure Policy

The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in a CME activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been resolved prior to this CME activity.

Faculty

Ileana L. Piña, MD, MPH, FAHA, FACC
Professor of Medicine, Wayne State University
Clinical Prof of Medicine, Central Michigan University
Director of CVD Research and Academic Affairs
Regional and National Director of Heart Failure
Detroit Medical Center, Cardiovascular Institute
Detroit, MI

Dr. Piña discloses the following:
Advisory Board: Relypsa, Inc.

Tariq Ahmad, MD, MPH, FACC
Assistant Professor of Medicine (Cardiology)
Advanced Heart Failure and Transplant Cardiologist
Investigator, Center for Outcomes Research and Evaluation
Yale University School of Medicine
Yale New Haven Health System
New Haven, CT

Dr. Ahmad discloses the following:
Consulting Agreements: Amgen Inc., Cytokinetics, Inc

Navin K. Kapur, MD, FAHA, FACC, FSCAI
Associate Professor, Dept of Medicine/Division of Cardiology
Executive Director, The CardioVascular Center for Research and Innovation (CVCRI)
Director, Acute Circulatory Support Program
Director, Interventional Research Laboratories
Investigator, Molecular Cardiology Research Institute
Tufts Medical Center
Boston, MA

Dr. Kapur discloses the following:
Grants/Research Support: Abiomed, Abbott, Boston Scientific, Maquet , MD Start, Medtronic
Consultant/Advisory Board: Abiomed, Abbott, Boston Scientific, Maquet , MD Start, Medtronic
Honorarium/Speakers Bureau: Abiomed, Abbott, Boston Scientific, Maquet , MD Start, Medtronic

Accredited Provider Disclosure

ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.

Credit

0.50

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement



The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement

The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 0.50 AMA PRA Category 1 CreditsTM  .  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Unlabeled Use

Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: Medical therapies and devices under investigation for HF.

Disclaimer

The content for this activity was developed independently of the commercial supporter. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor.

This educational activity was planned and produced in accordance with the ACCME Accreditation Criteria, Policies, and Standards for Commercial Support. Recommendations involving clinical medicine in a continuing medical education (CME) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.

This CME activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.

Instructions

This activity will take approximately 30 minutes to complete. To receive credit, participants are required to complete the pretest, view the online activity and complete the posttest and evaluation. To receive credit, 66% must be achieved on the posttest. A certificate will be immediately available and emailed, please be sure to check spam/junk mailbox. There is no fee to participate in the activity or for the generation of the certificate. Your certificate will be saved on the ACHL website and will not be available in your myCME CME History. If you cannot locate your certificate, please contact Melissa Stradal at mstradal@achclcme.org.

Privacy Policy

Add to Queue